Tag: NGSX

LBSR, TLON, NGSX, CLSP & Today’s Ext. Watchlist

Liberty Star Uranium & Metals Corp. LBSR

LBSR first appeared in our extended watchlist as a momentum play on July 3rd . When we returned from the holiday, we included it in our newsletter once again. At that time the stock was as low as .028. On Friday, the stock closed at .04.

We’ve pointed out a few key points on the chart in the following video.


____

Talon Therapeutics, Inc. TLON

TLON is the play we mentioned last week with an upcoming FDA Date. The company is set to receive results on August 12th on its leukimia treatment, Marquibo.

____

NeurogesX, Inc. NGSX

NGSX is a bottom bouncer that we included in Wednesday’s newsletter. We are still giving it some time, although we have already seen gains of 10-20% in the two days we’ve covered the play.

____

Callisto Pharmaceuticals, Inc. CLSP

Another one of our selections from Wednesday that is performing well for the short time we have been paying attention. CLSP was as low as .57 following our alert, and managed to close at .70 on Friday. If CLSP breaks through its previous resistance of .72, we could see a could turn to bluesky breakout mode.

____

07/21 $615 AAPL Calls (APPL Earnings Expected 07/24 Could run to $620+ into earnings.)

Recent release of the new iPad into Chinese markets, said to have had major effect on the company’s Q2 earnings.

_____

Extended Watchlist:

GPXM, EGCT,

ICPA, TLON & Today’s Extended Watchlist

We’d like to extend a big welcome to all of our new subscribers! Get ready for a new way of doing things! You made a great choice in signing on with us, and will soon notice that we’re not your average stock newsletter. We provide our readers with play after play, day after day, with little regard for our own interests. All we really care about is bringing you the best product we can, through careful coverage of many stocks at once. More often than not, we cover these stocks for long periods of time, waiting for just the right moment. Take our first mention today, ICPA. We have been on this one for a very long time, and have had our patience rewarded highly on more than one occasion as a result:

IC Places, Inc. ICPA

Our first mention of ICPA in the newsletter came on January 9th. At the time, the stock was trading as low as .0008, and since that time, the stock has provided us with many opportunities to gain as the one year chart shows.

At one point in the beginning of May, a high of .0585 was attained, however the nature of trading on this stock has given us the chance to rake in more than just the astonishing gain from triple-zero range to a nickel. Subsequent to that run, the stock pulled back to find support in the .02’s only to turn around and hit the nickel-range once again. ICPA has been a veritable cash cow for us at times, so our newest members will become familiar with this stock.

After another recent pullback in late June, we saw support form at the 200DMA (.0112).  ICPA now has broken the 100DMA at .0185, which we’d like to see become the new support. .

____

Talon Therapeutics, Inc. TLON

We picked up on this upcoming FDA play, and wanted to pass it along to you today. TLON is likely to become a target for many investors as we approach August 12, the company’s FDA PDUFA for their Phase III drug candidate Marqibo.

Some of you will remember ARNA, a recent FDA play that we covered quite successfully. The stock ran into its approval date, and scored approval, along with a serious surge in PPS. (5.44-13.50 in just about a month and a half)

If TLON enjoys even a fraction of the success garnered by ARNA, we’re in for quite a ride in coming weeks.

____

Extended Watchlist:
CLSP, NGSX (Bottom Bouncer), AAPT